197 related articles for article (PubMed ID: 19620844)
1. Intrinsic clotting factors in dependency of age, sex, body mass index, and oral contraceptives: definition and risk of elevated clotting factor levels.
Luxembourg B; Schmitt J; Humpich M; Glowatzki M; Seifried E; Lindhoff-Last E
Blood Coagul Fibrinolysis; 2009 Oct; 20(7):524-34. PubMed ID: 19620844
[TBL] [Abstract][Full Text] [Related]
2. Procoagulant factors and the risk of myocardial infarction in young women.
Tanis B; Algra A; van der Graaf Y; Helmerhorst F; Rosendaal F
Eur J Haematol; 2006 Jul; 77(1):67-73. PubMed ID: 16608503
[TBL] [Abstract][Full Text] [Related]
3. [Measurements of the activity of the coagulation factors VIII:C, IX,XI, and XII in cats].
Mischke R; Deniz A; Nolte I
Zentralbl Veterinarmed A; 1995 Oct; 42(8):513-20. PubMed ID: 8592897
[TBL] [Abstract][Full Text] [Related]
4. Increased coagulation factor VIII, IX, XI and XII activities in non-alcoholic fatty liver disease.
Kotronen A; Joutsi-Korhonen L; Sevastianova K; Bergholm R; Hakkarainen A; Pietiläinen KH; Lundbom N; Rissanen A; Lassila R; Yki-Järvinen H
Liver Int; 2011 Feb; 31(2):176-83. PubMed ID: 21134109
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular risk factors in idiopathic compared to risk-associated venous thromboembolism: A focus on fibrinogen, factor VIII, and high-sensitivity C-reactive protein (hs-CRP).
Luxembourg B; Schmitt J; Humpich M; Glowatzki M; Dressler D; Seifried E; Lindhoff-Last E
Thromb Haemost; 2009 Oct; 102(4):668-75. PubMed ID: 19806251
[TBL] [Abstract][Full Text] [Related]
6. Coagulation factor VIII, IX and XI levels in north Indian patients with venous thromboembolism: first study from India.
Chougule A; Rajpal S; Ahluwalia J; Bose SK; Masih J; Das R; Kumar N; Malhotra P; Suri V
Blood Coagul Fibrinolysis; 2016 Jan; 27(1):58-63. PubMed ID: 26340461
[TBL] [Abstract][Full Text] [Related]
7. Risk of deep vein thrombosis: interaction between oral contraceptives and high factor VIII levels.
Legnani C; Cini M; Cosmi B; Poggi M; Boggian O; Palareti G
Haematologica; 2004 Nov; 89(11):1347-51. PubMed ID: 15531457
[TBL] [Abstract][Full Text] [Related]
8. High levels of coagulation factor XI as a risk factor for venous thrombosis.
Meijers JC; Tekelenburg WL; Bouma BN; Bertina RM; Rosendaal FR
N Engl J Med; 2000 Mar; 342(10):696-701. PubMed ID: 10706899
[TBL] [Abstract][Full Text] [Related]
9. [Prothromboplastin factor group (factors VIII, IX, XI, XII)--interpretation of the test results].
Kagami M
Nihon Rinsho; 1973; 31():1721-33. PubMed ID: 4795303
[No Abstract] [Full Text] [Related]
10. [Determination of prothromboplastin factors (Factors VIII, IX, XI and XII)].
Kagami M
Nihon Rinsho; 1976; 34 suppl():2407-24. PubMed ID: 792517
[No Abstract] [Full Text] [Related]
11. Long-term prospective study of recurrent venous thromboembolism in a Hispanic population.
Mello TB; Orsi FL; Montalvao SA; Ozelo MC; de Paula EV; Annichinno-Bizzachi JM
Blood Coagul Fibrinolysis; 2010 Oct; 21(7):660-5. PubMed ID: 20829682
[TBL] [Abstract][Full Text] [Related]
12. Assessment of Actin FS and Actin FSL sensitivity to specific clotting factor deficiencies.
Lawrie AS; Kitchen S; Purdy G; Mackie IJ; Preston FE; Machin SJ
Clin Lab Haematol; 1998 Jun; 20(3):179-86. PubMed ID: 9681235
[TBL] [Abstract][Full Text] [Related]
13. High factor VIII levels independently predict venous thromboembolism in cancer patients: the cancer and thrombosis study.
Vormittag R; Simanek R; Ay C; Dunkler D; Quehenberger P; Marosi C; Zielinski C; Pabinger I
Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2176-81. PubMed ID: 19778945
[TBL] [Abstract][Full Text] [Related]
14. Absolute annual incidences of first events of venous thromboembolism and arterial vascular events in individuals with elevated FVIII:c. A prospective family cohort study.
Bank I; van de Poel MH; Coppens M; Hamulyák K; Prins MH; van der Meer J; Veeger NJ; Büller HR; Middeldorp S
Thromb Haemost; 2007 Nov; 98(5):1040-4. PubMed ID: 18000609
[TBL] [Abstract][Full Text] [Related]
15. Venous thrombosis of the upper extremity: effect of blood group and coagulation factor levels on risk.
Flinterman LE; van Hylckama Vlieg A; Rosendaal FR; Doggen CJ
Br J Haematol; 2010 Apr; 149(1):118-23. PubMed ID: 20096009
[TBL] [Abstract][Full Text] [Related]
16. Overweight, obesity, and the risk of recurrent venous thromboembolism.
Eichinger S; Hron G; Bialonczyk C; Hirschl M; Minar E; Wagner O; Heinze G; Kyrle PA
Arch Intern Med; 2008 Aug; 168(15):1678-83. PubMed ID: 18695082
[TBL] [Abstract][Full Text] [Related]
17. Co-segregation of thrombophilic disorders in factor V Leiden carriers; the contributions of factor VIII, factor XI, thrombin activatable fibrinolysis inhibitor and lipoprotein(a) to the absolute risk of venous thromboembolism.
Libourel EJ; Bank I; Meinardi JR; Baljé -Volkers CP; Hamulyak K; Middeldorp S; Koopman MM; van Pampus EC; Prins MH; Büller HR; van der Meer J
Haematologica; 2002 Oct; 87(10):1068-73. PubMed ID: 12368162
[TBL] [Abstract][Full Text] [Related]
18. Coagulation factors IX through XIII and the risk of future venous thrombosis: the Longitudinal Investigation of Thromboembolism Etiology.
Cushman M; O'Meara ES; Folsom AR; Heckbert SR
Blood; 2009 Oct; 114(14):2878-83. PubMed ID: 19617576
[TBL] [Abstract][Full Text] [Related]
19. [Evaluation of the KC10 semi-automatic modular clot detection device].
Crespo B; Ankri A; Lesty C
Nouv Rev Fr Hematol (1978); 1983; 25(2):113-21. PubMed ID: 6408609
[No Abstract] [Full Text] [Related]
20. Elevated factor VIII in hereditary haemorrhagic telangiectasia (HHT): association with venous thromboembolism.
Shovlin CL; Sulaiman NL; Govani FS; Jackson JE; Begbie ME
Thromb Haemost; 2007 Nov; 98(5):1031-9. PubMed ID: 18000608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
